Table III.

Reduced Aβ(1–42) content in hippocampal tissue (ng/μg).

Group	Day 7
Control	3.1±2.42
APP/PS1 untreated	38.62±11.84a
APP/PS1 treated	17.2±9.36b

^aP<0.05, compared with the control group;

^bP<0.05, compared with the APP/PS1 untreated group.